Krystal Biotech, Inc. - Common Stock (KRYS)

CUSIP: 501147102

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock
Shares outstanding
29,067,614
Total 13F shares
14,124,381
Share change
+2,607,189
Total reported value
$585,026,548
Put/Call ratio
106%
Price per share
$41.42
Number of holders
108
Value change
+$106,373,347
Number of buys
76
Number of sells
32

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
4%
1,148,286
$49,652,000 31 Mar 2020
13F
Redmile Group, LLC
13F
Company
3.6%
1,051,800
$45,480,000 31 Mar 2020
13F
BAKER BROS. ADVISORS LP
13F
Company
3.3%
946,471
$40,925,000 31 Mar 2020
13F
FRAZIER MANAGEMENT LLC
13F
Company
3.1%
895,000
$38,700,000 31 Mar 2020
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
3.1%
892,824
$38,606,000 31 Mar 2020
13F
BlackRock Finance, Inc.
13F
Company
2.8%
826,765
$35,750,000 31 Mar 2020
13F
Consonance Capital Management LP
13F
Company
2.3%
654,586
$28,304,000 31 Mar 2020
13F
VANGUARD GROUP INC
13F
Company
2.2%
638,048
$27,589,000 31 Mar 2020
13F
CREDIT SUISSE AG/
13F
Company
2%
580,436
$25,098,000 31 Mar 2020
13F
CITADEL ADVISORS LLC
13F
Company
1.9%
541,702
$23,423,000 31 Mar 2020
13F
STATE STREET CORP
13F
Company
1.6%
467,393
$20,210,000 31 Mar 2020
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
0.86%
250,000
$10,810,000 31 Mar 2020
13F
LORD, ABBETT & CO. LLC
13F
Company
0.75%
216,592
$9,365,000 31 Mar 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.57%
166,895
$7,216,000 31 Mar 2020
13F
NORTHERN TRUST CORP
13F
Company
0.51%
148,639
$6,427,000 31 Mar 2020
13F
PICTET ASSET MANAGEMENT LTD
13F
Company
0.51%
147,597
$6,382,000 31 Mar 2020
13F
C WorldWide Group Holding A/S
13F
Company
0.47%
135,809
$5,872,000 31 Mar 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.46%
132,417
$5,725,000 31 Mar 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.35%
100,764
$4,357,000 31 Mar 2020
13F
Artal Group S.A.
13F
Company
0.34%
100,000
$4,324,000 31 Mar 2020
13F
CWM, LLC
13F
Company
0.21%
62,112
$4,224,000 31 Mar 2020
13F
AVIVA PLC
13F
Company
0.32%
92,943
$4,019,000 31 Mar 2020
13F
Verition Fund Management LLC
13F
Company
0.3%
85,990
$3,718,000 31 Mar 2020
13F
Nicholas Investment Partners, LP
13F
Company
0.28%
81,916
$3,542,000 31 Mar 2020
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.25%
71,795
$3,104,000 31 Mar 2020
13F
Informed Momentum Co LLC
13F
Company
0.24%
69,430
$3,002,000 31 Mar 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.24%
68,903
$2,980,000 31 Mar 2020
13F
Bank of New York Mellon Corp
13F
Company
0.22%
65,219
$2,821,000 31 Mar 2020
13F
BLAIR WILLIAM & CO/IL
13F
Company
0.21%
60,881
$2,632,000 31 Mar 2020
13F
S Squared Technology, LLC
13F
Company
0.21%
60,215
$2,604,000 31 Mar 2020
13F
CITIGROUP INC
13F
Company
0.21%
59,709
$2,582,000 31 Mar 2020
13F
Atom Investors LP
13F
Company
0.17%
48,201
$2,084,000 31 Mar 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.16%
46,645
$2,017,000 31 Mar 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.14%
41,676
$1,802,000 31 Mar 2020
13F
Invesco Ltd.
13F
Company
0.12%
34,701
$1,501,000 31 Mar 2020
13F
ALPS ADVISORS INC
13F
Company
0.11%
31,470
$1,361,000 31 Mar 2020
13F
ArrowMark Colorado Holdings LLC
13F
Company
0.11%
30,544
$1,321,000 31 Mar 2020
13F
Global IMC LLC
13F
Company
0.1%
30,065
$1,300,000 31 Mar 2020
13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC
13F
Company
0.1%
28,219
$1,220,000 31 Mar 2020
13F
CHARTWELL INVESTMENT PARTNERS, LLC
13F
Company
0.09%
25,791
$1,115,000 31 Mar 2020
13F
Neuberger Berman Group LLC
13F
Company
0.09%
25,000
$1,081,000 31 Mar 2020
13F
MARTINGALE ASSET MANAGEMENT L P
13F
Company
0.09%
24,800
$1,073,000 31 Mar 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.08%
23,379
$1,011,000 31 Mar 2020
13F
Swiss National Bank
13F
Company
0.07%
21,800
$943,000 31 Mar 2020
13F
Allianz Asset Management GmbH
13F
Company
0.07%
21,652
$937,000 31 Mar 2020
13F
TD ASSET MANAGEMENT INC
13F
Company
0.07%
20,755
$897,000 31 Mar 2020
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.06%
18,849
$815,000 31 Mar 2020
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.06%
17,811
$770,000 31 Mar 2020
13F
UBS Group AG
13F
Company
0.06%
16,810
$727,000 31 Mar 2020
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.06%
16,200
$700,000 31 Mar 2020
13F

Institutional Holders of Krystal Biotech, Inc. - Common Stock (KRYS) as of Q2 2020

As of 30 Jun 2020, Krystal Biotech, Inc. - Common Stock (KRYS) was held by 108 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,124,381 shares. The largest 10 holders included Redmile Group, LLC, FMR LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, FRAZIER MANAGEMENT LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, STATE STREET CORP, CREDIT SUISSE AG/, and Point72 Asset Management, L.P.. This page lists 108 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
88
Q2 2020 holders
108
Holder diff
20
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 Value $ Q2 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.